Bill Sponsors: US HB3839 | 2023-2024 | 118th Congress

Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Spectrum: Bipartisan Bill

Status: (Introduced) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]

Text: Latest bill text (Introduced) [PDF]

Sponsors

NameTypeSponsorshipDistrictFinancialFinancialEncyclopediaBiographyBioGuide
Representative Neal Dunn [R]PrimarySponsored BillsHD-FL-2OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Ann Kuster [D]CosponsorSponsored BillsHD-NH-2OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide

Social Comments on US HB3839

feedback